Source |
Code |
Name |
Case count |
Share of cases (%) |
CANC |
CANC_TOPO(C809)_MORPHO(8000)_BEH(3) |
Unknown primary site, Neoplasm, malignant |
320 |
|
DEATH |
DEATH_ICD10(C80) |
Malignant neoplasm, without specification of site |
247 |
|
DEATH |
DEATH_ICD10(C800) |
Name not found |
169 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8140)_BEH(3) |
Unknown primary site, Adenocarcinoma, NOS |
165 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8070)_BEH(3) |
Unknown primary site, Squamous cell carcinoma, NOS |
111 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8010)_BEH(3) |
Unknown primary site, Carcinoma, NOS |
85 |
|
CANC |
CANC_TOPO(C809)_MORPHO(9680)_BEH(3) |
Unknown primary site, Malignant lymphoma, large B-cell, diffuse, NOS |
72 |
|
DEATH |
DEATH_ICD10(C809) |
Name not found |
63 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8246)_BEH(3) |
Unknown primary site, Neuroendocrine carcinoma, NOS |
43 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8720)_BEH(3) |
Unknown primary site, Malignant melanoma, NOS |
34 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8240)_BEH(3) |
Unknown primary site, Carcinoid tumor, NOS |
27 |
|
DEATH |
DEATH_ICD9(1990X) |
Disseminated malignant neoplasm without specification of site |
25 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8480)_BEH(3) |
Unknown primary site, Mucinous adenocarcinoma |
23 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8020)_BEH(3) |
Unknown primary site, Carcinoma, undifferentiated, NOS |
19 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8249)_BEH(3) |
Unknown primary site, Atypical carcinoid tumor |
18 |
|
CANC |
CANC_TOPO(C809)_MORPHO(8041)_BEH(3) |
Unknown primary site, Small cell carcinoma, NOS |
17 |
|
CANC |
CANC_TOPO(C809)_MORPHO(9591)_BEH(3) |
Unknown primary site, Malignant lymphoma, non-Hodgkin, NOS |
12 |
|
CANC |
CANC_TOPO(C809)_MORPHO(9590)_BEH(3) |
Unknown primary site, Malignant lymphoma, NOS |
11 |
|
CANC |
CANC_TOPO(C809)_MORPHO(9670)_BEH(3) |
Unknown primary site, Malignant lymphoma, small B lymphocytic, NOS |
10 |
|
CANC |
CANC_TOPO(C809)_MORPHO(9673)_BEH(3) |
Unknown primary site, Mantle cell lymphoma (Includes all variants: blastic, pleomorphic, small cell) |
9 |
|
CANC |
CANC_TOPO(C809)_MORPHO(9699)_BEH(3) |
Unknown primary site, Marginal zone B-cell lymphoma, NOS |
9 |
|
CANC |
CANC_TOPO(C809)_MORPHO(9702)_BEH(3) |
Unknown primary site, Mature t-cell lymphoma, NOS |
7 |
|
CANC |
CANC_TOPO(C809)_MORPHO(9671)_BEH(3) |
Unknown primary site, Malignant lymphoma, lymphoplasmacytic |
5 |
|